- MiMedx Group (OTC:MDXG +7%) charges ahead after its wound care allograft EpiFix receives coverage from Medicare contractor CGS. The move brings coverage from Medicare Administrative Contractors to six of eight, and 86% of Medicare beneficiaries will now be eligible for coverage for EpiFix products.
- Press release
MiMedx up 7% on expanding EpiFix Medicare coverage
Recommended For You
More Trending News
About MDXG Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MDXG | - | - |
MiMedx Group, Inc. |